This is the second episode in our Two Talking Fools series exploring 7-OH, kratom, addiction, withdrawal and recovery—because the more we learn about these products, the more we believe people need to be talking about them. In this solo episode, Kate sits down with Eric, who shares how taking a free sample of 7-OH eventually led to escalating daily use, multiple attempts to quit, dangerous relapses, and ultimately his fight to get his life back. Eric talks openly about 7-OH dependence and withdrawal, his experience using kratom and a rapid Suboxone taper while trying to stop, and how he later found greater stability with Wellbutrin and low-dose naltrexone. But Eric is just one of many people with a story like this. And 7-OH is only part of a much bigger conversation. Where Does 7-OH Stand Legally? As of August 25, 2026, concentrated 7-OH is not yet federally classified as Schedule I. However, the DEA has formally begun the process to temporarily place 7-OH above a proposed specified threshold into Schedule I, along with three related substances: mitragynine pseudoindoxyl, MGM-15 and MGM-16. This distinction matters. The federal action is not intended to target ordinary botanical kratom leaf containing naturally occurring trace amounts of 7-OH. It is aimed at concentrated, enhanced and synthetic 7-OH products and related substances that federal officials say present an emerging public-health threat. Once a temporary scheduling order takes effect, the covered substances would become subject to the federal restrictions and penalties associated with Schedule I controlled substances. But while regulators work to catch up with 7-OH, we keep coming back to an even bigger question: What comes next? What will be sitting on a shelf next year—or next month? How powerful will it be? How quickly will it become available? And will the average person have any idea what they're actually taking? That's what makes the packaging, marketing and accessibility of these products such an important part of this conversation. Concentrated 7-OH products have been sold online and in gas stations, smoke shops, convenience stores and corner stores in forms including tablets, capsules, powders, gummies and dissolvable strips. And sometimes, nothing about the package says “powerful opioid” to the person looking at it. That's the part we can't stop thinking about. Something can be brightly colored, professionally packaged, sitting next to products you've seen a hundred times—and still carry risks of dependence, addiction and opioid-like withdrawal. The FDA has warned consumers that concentrated 7-OH products are potent opioid products that have not been proven safe or effective for any medical use. So this series isn't only about 7-OH. It's about what happens when new substances reach consumers faster than education, awareness and regulation can keep up. At Two Talking Fools, we lead with compassion, not judgment. We want to hear from the people who lived it, ask the questions people may be afraid to ask, and help someone understand what they're getting into before they find themselves in the same situation. Eric also shares lessons from his recovery and discusses resources and community support available to people struggling with 7-OH. Eric's story is one story. There are many more. And we're going to keep talking about them.
